BlackRock’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $475M | Buy |
4,990,181
+1,463,094
| +41% | +$97.5M | 0.01% | 1253 |
|
|
2026
Q1 | $173M | Sell |
3,527,087
-12,328
| -0.3% | -$428K | ﹤0.01% | 1762 |
|
|
2025
Q4 | $107M | Buy |
3,539,415
+1,334,864
| +61% | +$37.2M | ﹤0.01% | 2069 |
|
|
2025
Q3 | $42.4M | Buy |
2,204,551
+215,671
| +11% | +$3.2M | ﹤0.01% | 2611 |
|
|
2025
Q2 | $22.3M | Buy |
1,988,880
+1,241,206
| +166% | +$12.9M | ﹤0.01% | 2954 |
|
|
2025
Q1 | $7.67M | Sell |
747,674
-3,757
| -0.5% | -$46.9K | ﹤0.01% | 3454 |
|
|
2024
Q4 | $14.6M | Buy |
751,431
+729,864
| +3,384% | +$17.8M | ﹤0.01% | 3228 |
|
|
2024
Q3 | $529K | Buy |
21,567
+908
| +4% | +$31.6K | ﹤0.01% | 4310 |
|
|
2024
Q2 | $949K | Buy |
20,659
+1,389
| +7% | +$55.4K | ﹤0.01% | 4194 |
|
|
2024
Q1 | $407K | Sell |
19,270
-56
| -0.3% | -$1.11K | ﹤0.01% | 4425 |
|
|
2023
Q4 | $394K | Sell |
19,326
-4
| -0% | -$90 | ﹤0.01% | 4481 |
|
|
2023
Q3 | $466K | Hold |
19,330
| – | – | ﹤0.01% | 4446 |
|
|
2023
Q2 | $471K | Sell |
19,330
-2,731
| -12% | -$67.2K | ﹤0.01% | 4496 |
|
|
2023
Q1 | $527K | Buy |
22,061
+88
| +0.4% | +$2.32K | ﹤0.01% | 4516 |
|
|
2022
Q4 | $625K | Buy |
21,973
+21
| +0.1% | +$538 | ﹤0.01% | 4545 |
|
|
2022
Q3 | $542K | Sell |
21,952
-73
| -0.3% | -$2.06K | ﹤0.01% | 4705 |
|
|
2022
Q2 | $658K | Sell |
22,025
-465
| -2% | -$13.1K | ﹤0.01% | 4682 |
|
|
2022
Q1 | $620K | Sell |
22,490
-154
| -0.7% | -$3.82K | ﹤0.01% | 4822 |
|
|
2021
Q4 | $585K | Buy |
22,644
+278
| +1% | +$8.38K | ﹤0.01% | 4834 |
|
|
2021
Q3 | $795K | Sell |
22,366
-421
| -2% | -$15.6K | ﹤0.01% | 4624 |
|
|
2021
Q2 | $954K | Sell |
22,787
-1,152
| -5% | -$48K | ﹤0.01% | 4528 |
|
|
2021
Q1 | $1.05M | Hold |
23,939
| – | – | ﹤0.01% | 4486 |
|
|
2020
Q4 | $1.15M | Hold |
23,939
| – | – | ﹤0.01% | 4183 |
|
|
2020
Q3 | $1.27M | Buy |
23,939
+23,935
| +598,375% | +$1.69M | ﹤0.01% | 4041 |
|
|
2020
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 5160 |
|
|
2020
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 5107 |
|
|
2019
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 5101 |
|
|
2019
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 5103 |
|
|
2019
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 5104 |
|
|
2019
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 5074 |
|
|
2018
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 5080 |
|
|
2018
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 5096 |
|
|
2018
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 5099 |
|
|
2018
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 5036 |
|
|
2017
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 4901 |
|
|
2017
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 4935 |
|
|
2017
Q2 | $2K | Sell |
4
-70
| -95% | -$36.5K | ﹤0.01% | 4918 |
|
|
2017
Q1 | $41K | Buy |
+74
| New | +$41.3K | ﹤0.01% | 4498 |
|
Other funds holding ORKA
VA
FFM
RI
PBA
DTC
BG
BlackRock's ORKA Position: Q2 2026 in Review
BlackRock increased its Oruka Therapeutics (ORKA) stake by 41% in Q2 2026, buying an estimated $97.5M and bringing the position to 4,990,181 shares worth $475M. The position accounts for 0.01% of the portfolio, ranked #1253.
BlackRock first reported a position in ORKA in Q1 2017 and has held it in 38 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.
- BlackRock held 4,990,181 shares of Oruka Therapeutics worth $475M as of Q2 2026.
- BlackRock bought 1,463,094 Oruka Therapeutics shares in Q2 2026, an estimated $97.5M.
- Oruka Therapeutics made up 0.01% of BlackRock's portfolio in Q2 2026, its #1253 holding.
- BlackRock first reported a position in Oruka Therapeutics in Q1 2017 and has held it in 38 quarters since.
- 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.